Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses.

Thomas K Le Subuhi Kaul Murthy Laura C Cappelli Jarushka Naidoo Yevgeniy R Semenov Shawn G Kwatra

Published in: The Journal of dermatological treatment (2021)

We report the frequency of dermatoses encountered in the setting of ICI therapy, both common (pruritus, rash, vitiligo) and uncommon (scleroderma, urticaria).

Keyphrases

systemic sclerosis
rheumatoid arthritis
mesenchymal stem cells
cell therapy
atopic dermatitis